Condition
Kidney Carcinoma
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 8 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
8 shownLight Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary CancersNCT05519878 · 2022-11-29
RECRUITINGCollecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionNCT05334069 · 2022-08-18
RECRUITINGFunctional Near-Infrared Spectroscopy and Virtual Reality Relaxation Programs for Pain Management in Patients With CancerNCT06456411 · 2022-07-12
TERMINATEDValidation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab DeviceNCT06789224 · 2022-02-15
COMPLETEDExperimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer TissuesNCT04147494 · 2019-11-05
ACTIVE_NOT_RECRUITINGSocial Media Listening in Improving Clinical Trial Recruitment in Patients With CancerNCT03408561 · 2017-11-08
WITHDRAWNBiospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing SurgeryNCT04955808 · 2017-02-07
SUSPENDEDTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)NCT02465060 · 2015-08-17
ACTIVE_NOT_RECRUITINGCommon interventions
Biospecimen CollectionPROCEDURE3Questionnaire AdministrationOTHER3Computed TomographyPROCEDURE2Laboratory Biomarker AnalysisOTHER218F-FDGRADIATION1AdavosertibDRUG1AfatinibDRUG1Afatinib DimaleateDRUG1Best PracticeOTHER1BinimetinibDRUG1Biopsy ProcedurePROCEDURE1Bright White Light TherapyDEVICE1CapivasertibDRUG1CATUVABDEVICE1Cold StimulationOTHER1CopanlisibDRUG1Copanlisib HydrochlorideDRUG1CrizotinibDRUG1Cytology Specimen Collection ProcedureOTHER1DabrafenibDRUG1Dabrafenib MesylateDRUG1DasatinibDRUG1DefactinibDRUG1Defactinib HydrochlorideDRUG1Echocardiography TestPROCEDURE1
Leading sponsors
Trial status mix
ACTIVE_NOT_RECRUITING2
RECRUITING2
COMPLETED1
SUSPENDED1
TERMINATED1
WITHDRAWN1
Phase mix
NA4
EARLY_PHASE11
PHASE21
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.